contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


correction-mentice-to-present-the-companys-year-end-q4-report-2024-via-webcast

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Mentice is a medical technology company. The company develops medical instruments for endovascular simulation and for training sessions in surgery. The programs are developed for educational use in hospitals and institutes. The largest operations are established in North America and Europe. In addition to the main business, the company also offers leasing, support, and technical service. The head office is located in Gothenburg. 

Mentice

Updated Time Webcast Conference CallMentice AB (STO: MNTC) announces that the company will present its Year-End Q4-2024 interim report for the period October – December via a webcast conference...

<div class="mfn-correction"><p>Updated Time Webcast Conference Call</p></div><div class="mfn-preamble"><p><strong>Mentice AB (STO: MNTC) announces that the company will present its Year-End Q4-2024 interim report for the period October – December via a webcast conference call on February 13, 2025, at 11:00 CET.</strong></p></div><div class="mfn-body"><p>During the webcast, CEO Frans Venker and CFO Ulrika Drotz will provide insights into the company's financial performance and strategic developments. The presentation will be followed by a Q&amp;A session, moderated by Carnegie analyst Rikard Engberg.</p><p>The presentation will be held in English, and participants are encouraged to register in advance.</p><p>For more information on how to join the webcast and participate, please visit <a rel="noopener" href="https://investor.mentice.com/">https://investor.mentice.com/</a>.</p></div><div class="mfn-footer mfn-fd823fcb349d"><p><strong>For more information, please contact:</strong><br>Stacy Hammar, Senior Marketing Manager, Mentice<br>E-post: <a rel="noopener" href="mailto:stacy.hammar@mentice.com">stacy.hammar@mentice.com</a><br>Mobile: +46 732 345 285</p></div><div class="mfn-footer mfn-about mfn-75d9119acc42"><p><strong class="mfn-heading-1">About Mentice</strong><br>Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: <a rel="noopener" href="http://www.mentice.com">www.mentice.com</a><br><br>Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC<br>Certified Adviser| FNCA Sweden AB</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/50893a53-0a2b-456c-85cd-b80bf91bb48c/mentice-to-present-the-companys-year-end-q4-report-2024-via-webcast.pdf" class="mfn-generated mfn-primary">Mentice to Present the Company's Year-End Q4 Report 2024 via Webcast</a></p></div>

Correction: Mentice to Present the Company's Year-End Q4 Report 2024 via Webcast